| Document |
Document Title |
|
WO/1999/001417A1 |
The present invention provides optically pure (S) 2-methylamino-2-phenyl-$i(n)-butyl 3,4,5-trimethoxybenzoate for use in the treatment of chronic pain, and having Formula (I). The present invention also provides methods of using the comp...
|
|
WO/1998/052907A1 |
The present invention relates to biodegradable softener compounds of the formula (1): [(R)�4-m?-N(?+�)-[(CH�2?)�n?-Y-R?1�]�m?] X(?-�) with an acid value of no more than 6.5. A process for making said compound is also provid...
|
|
WO/1998/050022A1 |
A new broad-spectrum anti-viral compound for the treatment of viral infections, such as human immune deficiency virus. The compound has general formula (I). Ar?1� and Ar?2� are each either a phenyl group or substituted aromatic group...
|
|
WO/1998/049132A1 |
A softening active substance for textiles and a textile-softening composition containing it are provided. The active substance is constituted by salts of oligomeric amine esters obtained by reacting triethanolamine with fatty acids and d...
|
|
WO/1998/047991A1 |
Fabric softener compounds having the formula: [RC(O)]�n?N?+�(R?1�)�m?X?-� wherein each R in a compound is a C�6?-C�22? hydrocarbyl group, preferably having an IV from about 70 to about 140 based upon the IV of the equivalen...
|
|
WO/1998/045394A2 |
The use of a composition represented by one of the following general formulae, formula (I): R�1?R�2?R�3?N, formula (II): R�1?R�2?R�3?N (HA)�y? or formula (III): R�1?R�2?R�3?N (QA)�y? or a mixture of two or more of t...
|
|
WO/1998/045233A2 |
The invention relates to $g(v)-amino acid derivatives of general formula (I), wherein R?1� is H or CH�3?, X is H or NR?2�R?3�, wherein R?2� is H, CH�3?, COH or COCH�3? and R?3� is H, CH�3? or COO?-�Z, wherein Z is R?2...
|
|
WO/1998/040337A1 |
An adamantane derivative having a functional group such as nitro, amino, hydroxyl, carboxyl, hydroxymethyl or isocyanato is oxidized with oxygen in the presence of an imide compound of general formula (2) (such as N-hydroxyphthalimide) o...
|
|
WO/1998/032718A1 |
The properties of biologically active compounds, for example drugs and agrochemicals, which contain in their molecular structure one or more functional groups selected from alcohol, ether, phenyl, amino, amido, thiol, carboxylic acid and...
|
|
WO/1998/031660A1 |
The present invention provides novel indane-like compounds which can be useful for treating conditions associated with the modulation of a muscarinic receptor. The invention provides novel processes and intermediates for preparing the no...
|
|
WO/1998/024753A1 |
Optically active 1-(substituted phenyl)-2-nitro alcohol derivatives represented by general formula (1) and a process for preparing the same, and 1-(substituted phenyl)-2-amino alcohol derivatives represented by general formula (2) and a ...
|
|
WO/1998/021253A1 |
The invention relates to polymers with antimicrobial properties, consisting of: a) 99-40 wt % non functional vinylically polymerizable monomers and b) 1-60 wt % functional vinylically polymerizable monomers of general formula (I) wherein...
|
|
WO/1998/019988A1 |
Briefly, in one aspect, the present invention provides compositions of open-chain, $g(a)-branched fluoroalkylcarbonyl fluorides, and derivatives thereof.
|
|
WO/1998/016522A2 |
The present invention pertains to new aminophenol derivates, their preparation and their use as fungicides.
|
|
WO/1998/013332A1 |
Compounds represented by general formula (I) and pharmaceutically acceptable salts thereof, useful as the remedies for nerve degeneration diseases such as neuropil degeneration diseases, wherein Ar is optionally substituted phenyl or an ...
|
|
WO/1998/011082A1 |
The present invention relates to new amino alcohol derivatives, process for the production thereof and medicaments and reagents containing these compounds. The subject of the invention is medicaments having the general formula (I) wherei...
|
|
WO/1998/004517A1 |
The invention relates to the use of compounds of general Formula (IA) wherein: A is an optionally substituted cycloalkane ring having 3 to 6 carbon atoms and attached at a single ring carbon atom thereof; Ar is phenyl or heteroaryl havin...
|
|
WO/1998/003618A1 |
A process for the preparation of a biodegradable fabric softening active is provided. The process comprises the steps of: a) providing a source of triglyceride and reacting said source of triglyceride to form a mixture, said mixture comp...
|
|
WO/1998/000390A1 |
Disclosed are racemates and optically active isomers of substituted aminobutyl derivatives of cyclohexylphenylglycolic acid, including esters, amides and keto isosteres, which possess smooth muscle spaxmolytic properties with reduced ant...
|
|
WO/1997/049666A1 |
The invention relates to a copolymer comprising (a) 30 to 95.5 wt.% of ethylene; (b) 4 to 40 wt.% of at least one vinyl ester of C2-6 monocarboxylic acids; (c) 0.5 to 30 wt.% of at least one (meth)acrylate of the general formula (I), the...
|
|
WO/1997/047588A1 |
Described is a method of preparing quaternary trialkanolamine ester salts or formula (I) in which X- is the anion of an inorganic or organic acid, Ra is a C1-C4 alkyl group; Rb and Rc, independently of each other, are a C1-C3 alkylene gr...
|
|
WO/1997/045514A1 |
A process is disclosed for making a solid composition comprising at least one quaternary ester ammonium compound and at least one substantially saturated fatty acid compound, a solid composition obtainable by that process, and a solid co...
|
|
WO/1997/042279A1 |
The present invention generally relates to a textile softening composition which comprises, as the softening agent, a quaternary ammonium salt which comprises a mixture of mono-, di- and tri-ester components, wherein the amount of dieste...
|
|
WO/1997/038966A2 |
The present invention provides compositions and methods for protecting cells from injury due to intrinsic membrane lysis, oxidation and/or invasion by destructive agents. Even more particularly, the present invention provides composition...
|
|
WO/1997/032955A1 |
There is provided a cationic ester surfactant comprising at least one ester linkage and at least one cationically charged group characterized in that said cationically charged group is an ammonium group substituted by at least one hydrox...
|
|
WO/1997/031889A1 |
There is provided a cationic ester surfactant comprising at least one ester linkage and at least one cationically charged group characterized in that said ester linkage is separated from said cationically charged group by a spacer group ...
|
|
WO/1997/031888A1 |
The invention concerns esterquats of the following formula (1), in which RCO is a C6-C22 aliphatic acyl group, R1 is a methyl group, R2 is a C1-C6 alkyl group, R3 is a C3-C6 alkyl group and X- is a halogen anion. These esterquats are pre...
|
|
WO/1997/023443A1 |
A process for the preparation of a compound or polymer having at least one functional group selected from hydroxyl, thiol, amino and carboxylic acid groups is characterized in that a compound or polymer (A) containing a group of formula ...
|
|
WO/1997/022577A1 |
The invention relates to amphiphilic compounds of the general formula (I) with at least two hydrophilic and at least two hydrophobic groups based on carbonic acid derivatives. The spacer A is an alphatic, cyclic or acyclic or an aromatic...
|
|
WO/1997/016405A1 |
Compounds, or their compositions, of general formula: A - X1 - NO2 or their salts, used as medicaments, wherein: A = R(COX)t; t = 0 or 1; X = O; X0 = X; R being (a) wherein: R1, R2 and R3 are alkyls; X1 is a bivalent linking group chosen...
|
|
WO/1997/015549A1 |
Phenylethanolamine compounds represented by general formula (I) and pharmacologically acceptable salts thereof which have a potent effect of stimulating 'beta'3 adrenaline receptors and a high selectivity for 'beta'3 adrenaline receptors...
|
|
WO/1997/013744A1 |
Compounds of formula (Ia) as potent, 'beta'1-specific beta blockers with a short duration of action in the systemic circulation, wherein R is 3',4'-dimethoxyphenyl, R1 is hydrogen, and R2 is selected from methyl, ethyl, propyl, isobutyl ...
|
|
WO/1997/013743A1 |
Amine containing compounds and their use in the generation of cytofectin: polynucleotide complexes for transfection of cells, formulations, counterions, and reaction conditions for maximizing the transfection include using cationic amine...
|
|
WO/1997/011935A1 |
Amine containing compounds and their use in the generation of cytofectin:polynucleotide complexes for transfection of cells, formulations, counterions, and reaction conditions for maximizing the transfection include using cationic amine ...
|
|
WO/1997/006162A1 |
The present invention provides an improved process for preparing (S)-4-{[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl}-2-o
xazolidinone which comprises: a) forming a carbamate of formula (III), from methyl 4-nitro-(L)-phenylalaninate ...
|
|
WO/1997/005150A1 |
Compounds of formulae I: (DIP)IrXqYr(Z), Ia: (DIP)IrXsYt(Z)2 and Ib: (DIP)Ir(Z)3 or mixtures of at least two of those compounds, wherein DIP is a ditertiary diphosphine, the two phosphine groups of which are bonded to a C2-, C3- or C4-ca...
|
|
WO/1997/002234A1 |
The invention concerns amphiphilic compounds of general formula (I) with at least two hydrophilic groups and at least two hydrophobic groups based on alkoxylated amines and/or alkoxylated fatty acid amides and di-, oligo- or polycarboxyl...
|
|
WO/1997/000239A1 |
Constitution: a composition for treating or preventing angina pectoris which comprises as the active ingredient a nitroxy derivative having the following general formula (I) or a pharmacologically acceptable salt of the same: R1NH - A - ...
|
|
WO/1997/000241A1 |
New cationic and polycationic amphiphiles are capable of building aggregates with macromolecules, in particular DNA or RNA. Also disclosed is their insertion into prokaryotic and eucaryotic cells. Compounds with a spermyl-dioleoyloxyprop...
|
|
WO/1996/040613A1 |
The invention relates to processes for producing di-(tertiary aminoalkyl) carbonate including the step of reacting a tertiary alkanolamine with methyl alkyl carbonate in the presence of a transesterification catalyst to form tertiary ami...
|
|
WO/1996/035661A1 |
Proposed are surfactants containing quaternary-nitrogen groups obtained by a) first esterifying aliphatic or aromatic, optionally hydroxy-substituted, di- and/or tricarboxylic acids with an amount of an aliphatic alcohol such that a part...
|
|
WO/1996/032102A1 |
A cationic amphipathic compound of formula (I), wherein A is a single bond, an NH-R' grouping or (a), where -R'- is a straight or branched, optionally substituted, saturated or unsaturated C1-22 aliphatic chain optionally interrupted by ...
|
|
WO/1996/029302A1 |
There are described liposomogenic UV absorbers, comprising a hydrophilic head group (=Z), a spacer (=W), a UV chromophore (Q) having an absorption in the range from 285 to 400 nm and at least one hydrophobic tail group (=A) of the formul...
|
|
WO/1996/023787A1 |
Compounds of formula (I), wherein A is a bivalent radical selected from: A1)-O-CO-, A2)-CH2-O-CO-, A3)-O-CH2-CO-, A4)-O-CH2-CH2-, A5-N(R1)-CO-, A6)-N(R1)-CO-CO-, A7)-N(R1)-CH2-CH2-, A8)-O-CH2-, where R1 is hydrogen or C1-4alkyl, and Am i...
|
|
WO/1996/023762A1 |
The invention concerns novel cationic and/or amphoteric oligomers obtained by: (a) condensing polyvalent hydroxycarboxylic acids with tertiary amines of formula (I), in which R1 and R2, independently of each other, stand for alkyl groups...
|
|
WO/1996/023761A1 |
The invention concerns novel cationic and/or amphoteric oligomers obtained by: (a) condensing dimeric fatty acids having an average of 36 to 54 carbon atoms with tertiary amines of formula (I), in which R1 and R2, independently of each o...
|
|
WO/1996/022276A1 |
A compound of general formula (I) or a pharmaceutically acceptable salt thereof or its hydrate, wherein R1 and R2 are each independently alkyl or alkenyl; R3 is optionally substituted aryl or an optionally substituted aromatic heterocycl...
|
|
WO/1996/019179A1 |
An esterified macromonomer within the scope of general formula (I), wherein Z is an organic moiety, R1 is hydrogen or a substituted or unsubstituted alkyl having from 1 to 12 carbon atoms, oxyalkyl having from 1 to 12 carbon atoms, alken...
|
|
WO/1996/017685A1 |
The invention relates to a process for producing tenside-stabilized colloids of mono- and bimetals of the group VIII and Ib of the periodic system which are isolable in the form of powder and which are soluble at a concentration of at le...
|
|
WO/1996/014290A1 |
Aqueous esterquat dispersions with improved wetting power are obtained by quaternising fatty acid alkanol amine esters in the presence of dispersant mixtures containing (a) alcohol polyethylene glycol ether of the formula (I) R1O(CH2CH2O...
|
